ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

CTMX CytomX Therapeutics Inc

4.69
0.19 (4.22%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
CytomX Therapeutics Inc CTMX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.19 4.22% 4.69 09:00:00
개장가 저가 고가 종가 전일 종가
4.62 4.45 5.06 4.43 4.50
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00GLOBECytomX Therapeutics to Report First Quarter 2024 Results and..
08/04/202421:00GLOBECytomX Therapeutics Announces First Patient Dosed with..
03/04/202421:00GLOBECytomX Therapeutics Announces Nomination of Second Clinical..
21/03/202421:00GLOBECytomX Therapeutics Appoints Dr. Zhen Su to Board of..
18/03/202421:00GLOBECytomX Therapeutics Announces Milestone Achievement in..
12/03/202405:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/03/202405:10GLOBECytomX Therapeutics Reports 2023 Financial Results and..
12/03/202405:02EDGAR2Form 8-K - Current report
12/03/202405:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/03/202419:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
04/03/202422:00GLOBECytomX Therapeutics to Report Fourth Quarter and Full Year..
27/02/202422:00GLOBECytomX Therapeutics to Present at Upcoming March Investor..
24/01/202422:00GLOBECytomX Therapeutics Announces FDA Clearance of IND..
20/01/202410:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202410:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202410:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202410:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202410:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202422:00GLOBECytomX Therapeutics to Present at the B. Riley Securities..
04/01/202422:00GLOBECytomX Therapeutics Outlines 2024 Company Priorities and..
23/12/202306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:00GLOBECytomX Therapeutics to Present at the 42nd Annual J.P...
20/12/202309:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202309:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202309:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202309:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202306:15GLOBECytomX Therapeutics Reports Third Quarter 2023 Financial..
08/11/202306:05EDGAR2Form 8-K - Current report
08/11/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:00GLOBECytomX Therapeutics to Present at Upcoming November Investor..
31/10/202321:00GLOBECytomX Therapeutics to Report Third Quarter 2023 Financial..
30/10/202321:00GLOBECytomX Therapeutics to Present Preclinical Data for..
19/10/202305:30GLOBECytomX Therapeutics Presents Preclinical Profile of..
23/09/202308:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/09/202308:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202305:05GLOBECytomX Therapeutics to Present at Upcoming September..
28/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
25/08/202305:05EDGAR2Form 8-K - Current report
16/08/202310:40EDGAR2Form S-3 - Registration statement under Securities Act of..
11/08/202305:05GLOBECytomX Therapeutics to Present at the H.C. Wainwright Immune..
09/08/202305:15GLOBECytomX Therapeutics Reports Second Quarter 2023 Financial..
09/08/202305:08EDGAR2Form 8-K - Current report
09/08/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/08/202321:00GLOBECytomX Therapeutics to Report Second Quarter 2023 Financial..
21/07/202306:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/07/202306:17EDGAR2Form 3 - Initial statement of beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock